Ann E. Kingston

Synthesis, Pharmacological Characterization, and Molecular Modeling of Heterobicyclic Amino Acids Related to (+)-2-Aminobicyclo[3.1.0]hexane- 2,6-dicarboxylic Acid (LY354740):  Identification of Two New Potent, Selective, and Systemically Active Agonists for Group II Metabotropic Glutamate Receptors

James A. Monn, Matthew J. Valli, Steven M. Massey et al. · Journal of Medicinal Chemistry · 1999 · 288 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

DHPG-induced LTD in area CA1 of juvenile rat hippocampus; characterisation and sensitivity to novel mGlu receptor antagonists

Stephen M. Fitzjohn, Ann E. Kingston, David Lodge et al. · Neuropharmacology · 1999 · 166 citations

Life Sciences, Neuroscience, Pharmacology +13

The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity

Stephen M. Fitzjohn, Zuner A. Bortolotto, Mary J. Palmer et al. · Neuropharmacology · 1998 · 162 citations

Life Sciences, Neuroscience, Pharmacology +14

(S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord

Nicola Thomas, Rebecca A. Wright, Patrick A. Howson et al. · Neuropharmacology · 2001 · 147 citations

Life Sciences, Neuroscience, Pharmacology +16

(+)-2-Methyl-4-carboxyphenylglycine (LY367385) selectively antagonises metabotropic glutamate mGluR1 receptors

Barry P. Clark, Stephen Baker, John Goldsworthy et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 134 citations

Life Sciences, Neuroscience, Pharmacology +12